topical imiquimod

JDD March 2021 Issue Highlights: From OTC Products for Acne to MMS for Genital Skin Cancer
JDD MARCH 2021 ISSUE
by NEXT STEPS IN DERM TEAM on
The March issue of the Journal of Drugs in Dermatology features an outstanding line-up of articles with topics ranging from OTC products for acne to Mohs Micrographic Surgery for genital skin cancer. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Advisors agreed that OTC products and skincare recommendations, in addition to the use of prescription medications, …

Continue reading "JDD March 2021 Issue Highlights: From OTC Products for Acne to MMS for Genital Skin Cancer"

Does This Skin Cancer Really Need Mohs?
by Yumeng Marina Li, MD on
Have you ever come across a patient with a skin cancer that you are not 100% sure should be treated with Mohs surgery or an alternative modality? Or a patient who comes back for a follow-up after skin cancer surgery with an undesirable scar and you wonder if you should have opted for a less invasive option? I certainly have. Some of these nagging questions were answered by a thoughtful, case-based …

Continue reading "Does This Skin Cancer Really Need Mohs?"

Basal Cell Carcinoma – Friday Pop Quiz 1/25
by NEXT STEPS IN DERM TEAM on
The patient had an extensive superficial basal cell carcinoma on the forehead treated with topical imiquimod and returned 4-weeks later with this reaction. Which cytokine is not activated by this medication? A. Tumor necrosis factor (TNF)-α B. Interferon (IFN)-α C. Interferon (IFN)-γ D. Interleukin (IL)-12 E. Interleukin (IL)-4 To find out the correct answer and read the explanation …

Continue reading "Basal Cell Carcinoma – Friday Pop Quiz 1/25"